Activist 13D/13G Filings - Autolus Therapeutics plc

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-07-10
5:00 pm
Purchase
13GAutolus Therapeutics plc
AUTL
Paradigm Biocapital Advisors LP10,098,584
5.8%
10,098,584increase
(New Position)
View
2023-03-20
09:13 am
Purchase
13GAutolus Therapeutics plc
AUTL
Tetragon Financial Management LP9,461,883
5.5%
9,461,883increase
(New Position)
View
2023-02-14
5:02 pm
Purchase
13GAutolus Therapeutics plc
AUTL
Nantahala Capital Management LLC7,782,018
4.7%
3,704,509increase
(+90.85%)
View
2023-02-14
12:09 pm
Purchase
13GAutolus Therapeutics plc
AUTL
Frazier Life Sciences Public Fund L.P.3,746,857
2.2%
16,200increase
(+0.43%)
View
2023-02-14
12:02 pm
Purchase
13GAutolus Therapeutics plc
AUTL
ARMISTICE CAPITAL LLC10,224,000
5.91%
10,224,000increase
(New Position)
View
2023-02-14
10:28 am
Purchase
13GAutolus Therapeutics plc
AUTL
Syncona Portfolio Ltd33,527,162
19.7%
14,000,000increase
(+71.70%)
View
2023-02-14
08:30 am
Unchanged
13GAutolus Therapeutics plc
AUTL
Deep Track Capital LP15,000,000
8.67%
0
(Unchanged)
View
2023-02-13
2:49 pm
Sale
13GAutolus Therapeutics plc
AUTL
Capital World Investors625,000
0.4%
-2,330,806decrease
(-78.86%)
View
2022-12-19
4:11 pm
Purchase
13GAutolus Therapeutics plc
AUTL
Deep Track Capital LP15,000,000
9.03%
15,000,000increase
(New Position)
View
2022-12-13
4:51 pm
Purchase
13DAutolus Therapeutics plc
AUTL
Blackstone Inc.
BX
23,750,917
14%
2,500,000increase
(+11.76%)
View
2022-12-13
4:50 pm
Purchase
13GAutolus Therapeutics plc
AUTL
Qatar Investment Authority15,000,000
9.03%
15,000,000increase
(New Position)
View
2022-10-05
4:21 pm
Purchase
13DAutolus Therapeutics plc
AUTL
PPF Biotech B.V.14,613,275
16.1%
1,000increase
(+0.01%)
View
2022-02-14
5:03 pm
Purchase
13GAutolus Therapeutics plc
AUTL
Nantahala Capital Management LLC4,077,509
5.6%
4,077,509increase
(New Position)
View
2022-02-11
12:21 pm
Purchase
13GAutolus Therapeutics plc
AUTL
Syncona Portfolio Ltd19,527,162
26.8%
3,571,428increase
(+22.38%)
View
2021-12-17
2:37 pm
Purchase
13GAutolus Therapeutics plc
AUTL
Frazier Life Sciences Public Fund L.P.3,730,657
5.1%
3,730,657increase
(New Position)
View
2021-11-16
4:07 pm
Purchase
13DAutolus Therapeutics plc
AUTL
Blackstone Inc.
BX
21,250,917
22.6%
21,250,917increase
(New Position)
View
2021-06-23
4:00 pm
Purchase
13DAutolus Therapeutics plc
AUTL
PPF Biotech B.V.14,612,275
27.9%
361,255increase
(+2.53%)
View
2021-02-17
5:01 pm
Sale
13DAutolus Therapeutics plc
AUTL
Arix Bioscience plc3,319,866
4.8%
-50,000decrease
(-1.48%)
View
2021-02-16
11:42 am
Purchase
13GAutolus Therapeutics plc
AUTL
Capital World Investors2,955,806
5.7%
2,955,806increase
(New Position)
View
2021-02-12
10:43 am
Purchase
13GAutolus Therapeutics plc
AUTL
Syncona Portfolio Ltd15,955,734
30.5%
1,363,636increase
(+9.35%)
View
Goto 0, 1, Next